1. Home
  2. INBX vs TSLX Comparison

INBX vs TSLX Comparison

Compare INBX & TSLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Inhibrx Inc.

INBX

Inhibrx Inc.

HOLD

Current Price

$93.58

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Logo Sixth Street Specialty Lending Inc.

TSLX

Sixth Street Specialty Lending Inc.

HOLD

Current Price

$17.32

Market Cap

1.6B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
INBX
TSLX
Founded
2010
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.6B
IPO Year
2024
2011

Fundamental Metrics

Financial Performance
Metric
INBX
TSLX
Price
$93.58
$17.32
Analyst Decision
Buy
Buy
Analyst Count
3
9
Target Price
$150.00
$21.61
AVG Volume (30 Days)
331.5K
803.0K
Earning Date
05-15-2026
05-05-2026
Dividend Yield
N/A
10.82%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,300,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$1.20
P/E Ratio
N/A
N/A
Revenue Growth
550.00
N/A
52 Week Low
$20.55
$16.04
52 Week High
$155.29
$25.17

Technical Indicators

Market Signals
Indicator
INBX
TSLX
Relative Strength Index (RSI) 44.79 53.72
Support Level $85.94 $17.20
Resistance Level $96.12 $18.05
Average True Range (ATR) 7.44 0.48
MACD 0.78 0.07
Stochastic Oscillator 33.00 65.95

Price Performance

Historical Comparison
INBX
TSLX

About INBX Inhibrx Inc.

Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.

About TSLX Sixth Street Specialty Lending Inc.

Sixth Street Specialty Lending Inc is a specialty finance company focused on providing flexible, fully committed financing solutions to middle market companies located in the United States of America. The company partners with other companies across a variety of industries and provides creative solutions with complex business models that may have limited access to capital. The company seeks to generate current income in U.S.-domiciled middle-market companies through direct originations of senior secured loans and, to a lesser extent, originations of mezzanine and unsecured loans and investments in corporate bonds and equity securities.

Share on Social Networks: